125 related articles for article (PubMed ID: 12145813)
1. Gene therapy by intrahepatic and intratumoral trafficking of p53-VP22 induces regression of liver tumors.
Zender L; Köck R; Eckhard M; Frericks B; Gösling T; Gebhardt T; Drobek S; Galanski M; Kühnel F; Manns M; Kubicka S
Gastroenterology; 2002 Aug; 123(2):608-18. PubMed ID: 12145813
[TBL] [Abstract][Full Text] [Related]
2. VP22-mediated intercellular transport of p53 in hepatoma cells in vitro and in vivo.
Zender L; Kühnel F; Köck R; Manns M; Kubicka S
Cancer Gene Ther; 2002 Jun; 9(6):489-96. PubMed ID: 12032659
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral spread and increased efficacy of a p53-VP22 fusion protein expressed by a recombinant adenovirus.
Wills KN; Atencio IA; Avanzini JB; Neuteboom S; Phelan A; Philopena J; Sutjipto S; Vaillancourt MT; Wen SF; Ralston RO; Johnson DE
J Virol; 2001 Sep; 75(18):8733-41. PubMed ID: 11507218
[TBL] [Abstract][Full Text] [Related]
4. Poor intercellular transport and absence of enhanced antiproliferative activity after non-viral gene transfer of VP22-P53 or P53-VP22 fusions into p53 null cell lines in vitro or in vivo.
Zavaglia D; Lin EH; Guidetti M; Pluquet O; Hainaut P; Favrot MC; Coll JL
J Gene Med; 2005 Jul; 7(7):936-44. PubMed ID: 15754307
[TBL] [Abstract][Full Text] [Related]
5. VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion construct.
Hakkarainen T; Wahlfors T; Meriläinen O; Loimas S; Hemminki A; Wahlfors J
J Gene Med; 2005 Jul; 7(7):898-907. PubMed ID: 15759279
[TBL] [Abstract][Full Text] [Related]
6. Efficient translocation and apoptosis induction by adenovirus encoded VP22-p53 fusion protein in human tumor cells in vitro.
Roy I; Holle L; Song W; Holle E; Wagner T; Yu X
Anticancer Res; 2002; 22(6A):3185-9. PubMed ID: 12530063
[TBL] [Abstract][Full Text] [Related]
7. Herpes simplex virus VP22 enhances adenovirus-mediated microdystrophin gene transfer to skeletal muscles in dystrophin-deficient (mdx) mice.
Xiong F; Xiao S; Peng F; Zheng H; Yu M; Ruan Y; Li W; Shang Y; Zhao C; Zhou W; Chen H; Chamberlain JS; Fang L; Zhang C
Hum Gene Ther; 2007 Jun; 18(6):490-501. PubMed ID: 17550336
[TBL] [Abstract][Full Text] [Related]
8. Enhanced suicide gene effect by adenoviral transduction of a VP22-cytosine deaminase (CD) fusion gene.
Wybranietz WA; Gross CD; Phelan A; O'Hare P; Spiegel M; Graepler F; Bitzer M; Stähler P; Gregor M; Lauer UM
Gene Ther; 2001 Nov; 8(21):1654-64. PubMed ID: 11895004
[TBL] [Abstract][Full Text] [Related]
9. Evidence for intercellular trafficking of VP22 in living cells.
Lemken ML; Wolf C; Wybranietz WA; Schmidt U; Smirnow I; Bühring HJ; Mack AF; Lauer UM; Bitzer M
Mol Ther; 2007 Feb; 15(2):310-9. PubMed ID: 17235309
[TBL] [Abstract][Full Text] [Related]
10. Induction of insolubility by herpes simplex virus VP22 precludes intercellular trafficking of N-terminal Apoptin-VP22 fusion proteins.
Rutjes SA; Bosma PJ; Rohn JL; Noteborn MH; Wesseling JG
J Mol Med (Berl); 2003 Sep; 81(9):558-65. PubMed ID: 12879152
[TBL] [Abstract][Full Text] [Related]
11. Diffusible VP22-E2 protein kills bystander cells and offers a route for cervical cancer gene therapy.
Green KL; Southgate TD; Mulryan K; Fairbairn LJ; Stern PL; Gaston K
Hum Gene Ther; 2006 Feb; 17(2):147-57. PubMed ID: 16454648
[TBL] [Abstract][Full Text] [Related]
12. VP22 mediates intercellular trafficking and enhances the in vitro antitumor activity of PTEN.
Yu X; Xu Z; Lei J; Li T; Wang Y
Mol Med Rep; 2015 Jul; 12(1):1286-90. PubMed ID: 25816150
[TBL] [Abstract][Full Text] [Related]
13. Engineered cell therapy for sustained local myocardial delivery of nonsecreted proteins.
Bian J; Kiedrowski M; Mal N; Forudi F; Penn MS
Cell Transplant; 2006; 15(1):67-74. PubMed ID: 16700331
[TBL] [Abstract][Full Text] [Related]
14. HSV-1 VP22 augments adenoviral gene transfer to CNS neurons in the retina and striatum in vivo.
Kretz A; Wybranietz WA; Hermening S; Lauer UM; Isenmann S
Mol Ther; 2003 May; 7(5 Pt 1):659-69. PubMed ID: 12718909
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of lentivirus-mediated and MUC1 antibody-targeted VP22-TK/GCV suicide gene therapy for ovarian cancer.
Kong B; Wang W; Liu C; Song L; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Wang B; Wei MQ; Yang Q
In Vivo; 2003; 17(2):153-6. PubMed ID: 12792977
[TBL] [Abstract][Full Text] [Related]
16. Enhanced effect of microdystrophin gene transfection by HSV-VP22 mediated intercellular protein transport.
Xiong F; Xiao S; Yu M; Li W; Zheng H; Shang Y; Peng F; Zhao C; Zhou W; Chen H; Fang L; Chamberlain JS; Zhang C
BMC Neurosci; 2007 Jul; 8():50. PubMed ID: 17617925
[TBL] [Abstract][Full Text] [Related]
17. Fusion of HSV-1 VP22 to a bifunctional chimeric SuperCD suicide gene compensates for low suicide gene transduction efficiencies.
Lemken ML; Graepler F; Wolf C; Wybranietz WA; Smirnow I; Schmidt U; Gregor M; Bitzer M; Lauer UM
Int J Oncol; 2007 May; 30(5):1153-61. PubMed ID: 17390017
[TBL] [Abstract][Full Text] [Related]
18. Antitumor efficacy of VP22-CD/5-FC suicide gene system mediated by lentivirus in a murine uveal melanoma model.
Liu S; Song W; Liu F; Zhang J; Zhu S
Exp Eye Res; 2018 Jul; 172():144-151. PubMed ID: 29660328
[TBL] [Abstract][Full Text] [Related]
19. VP22-mediated intercellular transport correlates with enhanced biological activity of MybEngrailed but not (HSV-I) thymidine kinase fusion proteins in primary vascular cells following non-viral transfection.
Sheridan PJ; Lawrie A; Crossman DC; Holt CM; Newman CM
J Gene Med; 2005 Mar; 7(3):375-85. PubMed ID: 15543525
[TBL] [Abstract][Full Text] [Related]
20. Quantification of VP22-GFP spread by direct fluorescence in 15 commonly used cell lines.
Wybranietz WA; Prinz F; Spiegel M; Schenk A; Bitzer M; Gregor M; Lauer UM
J Gene Med; 1999; 1(4):265-74. PubMed ID: 10738559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
